306 related articles for article (PubMed ID: 28646793)
1. Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
Huang F; Liu Y; Yang X; Che D; Qiu K; Hammock BD; Wang J; Wang MH; Chen J; Huang H
Atherosclerosis; 2017 Aug; 263():184-191. PubMed ID: 28646793
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of angiogenesis promotion with Shexiang Baoxin Pills by regulating function and signaling pathway of endothelial cells through macrophages.
Zhang J; Cui Q; Zhao Y; Guo R; Zhan C; Jiang P; Luan P; Zhang P; Wang F; Yang L; Yang X; Xu Y
Atherosclerosis; 2020 Jan; 292():99-111. PubMed ID: 31785495
[TBL] [Abstract][Full Text] [Related]
3. Chinese medicine GeGen-DanShen extract protects from myocardial ischemic injury through promoting angiogenesis via up-regulation of VEGF/VEGFR2 signaling pathway.
Zhai S; Zhang XF; Lu F; Chen WG; He X; Zhang CF; Wang CZ; Yuan CS
J Ethnopharmacol; 2021 Mar; 267():113475. PubMed ID: 33068653
[TBL] [Abstract][Full Text] [Related]
4. Shexiang Baoxin Pill Attenuates Ischemic Injury by Promoting Angiogenesis by Activation of Aldehyde Dehydrogenase 2.
Hu J; Zhao Y; Wu Y; Yang K; Hu K; Sun A; Ge J
J Cardiovasc Pharmacol; 2021 Mar; 77(3):408-417. PubMed ID: 33662981
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomics reveals Shexiang Baoxin Pill exerts cardioprotective effects by preserving energy metabolism in a rat model of myocardial infarction.
Yu F; Yu Y; Tian S; Zhou Y; Chen X; Ye J; Liu Q; Xu X; Zhou H; Zhang W
J Ethnopharmacol; 2021 Feb; 266():113460. PubMed ID: 33039626
[TBL] [Abstract][Full Text] [Related]
6. Danggui Buxue decoction promotes angiogenesis by up-regulation of VEGFR
Hu G; Yang P; Zeng Y; Zhang S; Song J
J Chin Med Assoc; 2018 Jan; 81(1):37-46. PubMed ID: 28882731
[TBL] [Abstract][Full Text] [Related]
7. Exploring the mechanism underlying the cardioprotective effect of shexiang baoxin pill on acute myocardial infarction rats by comprehensive metabolomics.
Wu G; Chen L; Gu Y; Hong Y; Ma J; Zheng N; Zhong J; Liu AJ; Sheng L; Zhang W; Li H
J Ethnopharmacol; 2020 Sep; 259():113001. PubMed ID: 32464316
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
[TBL] [Abstract][Full Text] [Related]
9. Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction.
Zhu H; Jiang X; Li X; Hu M; Wan W; Wen Y; He Y; Zheng X
Heart Vessels; 2016 Jun; 31(6):963-75. PubMed ID: 26142379
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction: A single-center, double-blind, randomized controlled trial.
Yang Y; Gao S; Fang Q; Zhu M
Medicine (Baltimore); 2021 Jan; 100(3):e24246. PubMed ID: 33546045
[TBL] [Abstract][Full Text] [Related]
11. [Effects of shexiang baoxin pill on angiogenesis in atherosclerosis plaque and ischemic myocardium].
Shen W; Fan WH; Shi HM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1284-7. PubMed ID: 21302492
[TBL] [Abstract][Full Text] [Related]
12. Naoxintong inhibits myocardial infarction injury by VEGF/eNOS signaling-mediated neovascularization.
Wang H; Qiu L; Ma Y; Zhang L; Chen L; Li C; Geng X; You X; Gao X
J Ethnopharmacol; 2017 Sep; 209():13-23. PubMed ID: 28669772
[TBL] [Abstract][Full Text] [Related]
13. Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium.
Quan Z; Wang QL; Zhou P; Wang GD; Tan YZ; Wang HJ
Int J Mol Med; 2017 Jun; 39(6):1347-1356. PubMed ID: 28440414
[TBL] [Abstract][Full Text] [Related]
14. Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction.
Song N; Lu D; Wu G; Wang S; Zeng Y; Zhao J; Meng Q; He H; Chen L; Zhu H; Liu A; Li H; Shen X; Zhang W; Zhou H
J Ethnopharmacol; 2022 Jul; 293():115279. PubMed ID: 35405256
[TBL] [Abstract][Full Text] [Related]
15. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
[TBL] [Abstract][Full Text] [Related]
16. [Effect of medicines for activating blood and reinforcing Qi on angiogenesis in infarcted myocardium edge area of acute myocardial infarction model in rats].
Zang WH; Yin SH; Tang DC; Li BB
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):901-6. PubMed ID: 25204187
[TBL] [Abstract][Full Text] [Related]
17. Astragalosides promote angiogenesis via vascular endothelial growth factor and basic fibroblast growth factor in a rat model of myocardial infarction.
Yu JM; Zhang XB; Jiang W; Wang HD; Zhang YN
Mol Med Rep; 2015 Nov; 12(5):6718-26. PubMed ID: 26352430
[TBL] [Abstract][Full Text] [Related]
18. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
19. Huoxue Anxin Recipe () promotes myocardium angiogenesis of acute myocardial infarction rats by up-regulating miR-210 and vascular endothelial growth factor.
Wang J; Zhang Y; Liu YM; Guo LL; Wu P; Dong Y; Wu GJ
Chin J Integr Med; 2016 Sep; 22(9):685-90. PubMed ID: 27392480
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH
Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
